Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomised trial
Year: 2001
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: The Lancet
Author: H White
Institution: Greenlane Clinical Centre
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Medicines Company
OpenAlex ID: W2471145122